Sterling Capital Management’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.85K Sell
786
-17
-2% -$100 ﹤0.01% 2964
2026
Q2
$3.87K Buy
803
+561
+232% +$3.39K ﹤0.01% 2754
2026
Q1
$1.49K Hold
242
– – ﹤0.01% 3040
2025
Q4
$2.52K Buy
242
+158
+188% +$1.58K ﹤0.01% 3036
2025
Q3
$755 Sell
84
-2
-2% -$18 ﹤0.01% 3116
2025
Q2
$1.12K Buy
86
+48
+126% +$722 ﹤0.01% 3046
2025
Q1
$960 Hold
38
– – ﹤0.01% 2834
2024
Q4
$1.31K Buy
38
+3
+9% +$135 ﹤0.01% 2884
2024
Q3
$1.73K Buy
+35
New +$1.79K ﹤0.01% 2249

Other funds holding RXST

Sterling Capital Management's RXST Position: Q3 2026 in Review

Sterling Capital Management reduced its RxSight (RXST) stake by 2.1% in Q3 2026, selling an estimated $100 and leaving 786 shares worth $3.85K. The position accounts for ﹤0.01% of the portfolio, ranked #2964.

Sterling Capital Management first reported a position in RXST in Q3 2024 and has held it in 9 quarters since. The position peaked at $3.87K in Q2 2026. 153 funds tracked by Wall St. Rank hold RXST as of Q3 2026.

  • Sterling Capital Management held 786 shares of RxSight worth $3.85K as of Q3 2026.
  • Sterling Capital Management sold 17 RxSight shares in Q3 2026, an estimated $100.
  • RxSight made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2964 holding.
  • Sterling Capital Management first reported a position in RxSight in Q3 2024 and has held it in 9 quarters since.
  • Sterling Capital Management's RxSight position peaked at $3.87K in Q2 2026.
  • 153 funds tracked by Wall St. Rank held RxSight as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.